Results 151 to 160 of about 37,091 (247)

Cannabinoids for the control of experimental multiple sclerosis

open access: yes, 2010
PhDThere have been numerous studies reporting that cannabinoids, both exogenous and endogenous, have a potential beneficial function during incidences of neurological damage.
Pryce, Gareth
core  

Endocannabinoid System-Related Inflammation and Progression of Autosomal Dominant Polycystic Kidney Disease. [PDF]

open access: yesInt J Mol Sci
Simankowicz P   +5 more
europepmc   +1 more source

Maternal deprivation and adolescent alcohol exposure induce sex-dependent alterations in stress-related behavior and lipid signaling in rats. [PDF]

open access: yesBiol Sex Differ
Sánchez-Marín L   +8 more
europepmc   +1 more source

Corrigendum: Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal antihyperalgesic effect

open access: yesFrontiers in Pharmacology
Stefania Petrosino   +15 more
doaj   +1 more source

Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis. [PDF]

open access: yesFront Neurol
Annovazzi P   +8 more
europepmc   +1 more source

CANNABINOID 2 RECEPTOR AND GPR55 AS THERAPEUTIC TARGETS IN EXPERIMENTAL SEPSIS

open access: yes, 2016
Sepsis represents a dysregulated systemic acute inflammatory response to severe infection. Despite efforts to develop supportive sepsis therapies, none has been approved that address the immune dysregulation.
Yang, Olivia Hyewon
core  

Home - About - Disclaimer - Privacy